A team from the University of Sheffield has designed and built a specialist microscope and shared the build instructions to help make this equipment available worldwide.

A new study has found that a commonly prescribed antidepressant may halt the growth of childhood sarcoma, in mice and laboratory cell-based experiments.

Unrelated mutations, when present in the blood, can lead to false positive results in men with advanced prostate cancer who are undergoing liquid biopsies.

Researchers have generated a resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms, and identify optimal combination treatment strategies.

New research shows that bilateral neuroblastoma cancers can arise independently from each other, rather than having metastasized from one site to another. This finding has important implications for understanding the origins of neuroblastoma and could help the development of more efficacious treatments.

Immunotherapy for stomach cancer may work better if it is administered to the patient sooner, in the earlier stages of disease, and in combination with standard chemotherapy, a new study suggests.

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.

Dr Robert Nagourney is having success investigating whether a unique combination of existing and approved cancer drugs might be more effective compared to “off-the-shelf” treatments. Technology Networks recently had the pleasure of speaking with Nagourney to learn more about his work focused on repurposing drugs. He discusses the challenges and benefits of exploring new uses for drugs that are outside the scope of their original indication.

To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.

A profile piece exploring the life and career of the molecular biologist Professor Oded Rechavi.

Here, we review the most commonly adopted technologies and workflows available for single-cell sequencing and discuss current research studies adopting such approaches.

The medical profession had to think on its feet responding to the demands of the pandemic. But, in doing so, every medical discipline from general practice to palliative care has taken a hit. Of particular concern is how delays to screening, diagnosis and treatment of cancer have already impacted morbidity and mortality rates, with cancer death rates looking likely to rise significantly over the coming years.